WuXi AppTec (02359) continues to build global capabilities and scale in CRDMO.

On January 15, according to the presentation materials from WuXi AppTec (02359) at the J.P. Morgan Healthcare Conference (JPM), the continued strong operating cash flow will be used to advance global production capacity and capability building, with the expectation that D&M capital expenditures will double by 2025. According to the materials, WuXi AppTec has at least 6 bases worldwide that are either expanding or under construction.